UPDATE: Evogene Q3 EPS Cont Operations $(0.17) Beats $(0.19) Estimate

Benzinga · 1d ago

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 37.04 percent increase over losses of $(0.27) per share from the same period last year.